【摘要】 目的:观察莫西沙星治疗非淋菌性尿道(宫颈)炎的临床疗效。方法:对70例由沙眼衣原体和/或解脲支原体引起的非淋菌性尿道(宫颈)炎患者,采用莫西沙星口服,每次400mg,每日一次,连续10-12天。结果: 70例患者临床治愈率66.7%,总有效率84.6%。其中沙眼衣原体感染和解脲支原体感染患者的临床治愈率和总有效率分别为67.5%、85%和65.8%、84.2%。总副作用发生率为5.6%。结论:莫西沙星治疗非淋菌性尿道(宫颈)炎,临床疗效及患者的耐受性均较好,值得推广应用。更多还原

【Abstract】 Objective: To observe the clinical efficacy of Moxifloxacin in treating patients with non - gonococcal urethritis(cervicitis) . Methods: Seventy patients with non - gonococcal urethritis (cervicitis) caused by Chlamydia tiachomatis (CT) and/or Ureaplasma urealyticum(UU) were involved. All patients were given Moxifloxacin 400mg orally once a day for 10 -12 days. Results:The overall clinical cure rate and effective rate were 66.7% and 84.6% respectively. For patients with CT infection, the clinical cure rate and effective rate were 67.5% and 85%, while for patients with UU infection, they were 65.8% and 84.2% . The side effect of Moxifloxacin in the observation was 5.6% . Conclusions: Moxifloxacin has high efficacy and good tolarance in treating non-gonococcal urethritis (cervicitis) .更多还原